Evaluation of DNA from the Papanicolaou Test to Detect Ovarian and Endometrial Cancers-Reference-Cited by-同舟云学术

Evaluation of DNA from the Papanicolaou Test to Detect Ovarian and Endometrial Cancers

Published:2013-01-09 Issue:167 Volume:5 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Kinde Isaac¹,Bettegowda Chetan¹²,Wang Yuxuan¹,Wu Jian¹³,Agrawal Nishant¹⁴,Shih Ie-Ming⁵,Kurman Robert⁵,Dao Fanny⁶,Levine Douglas A.⁶,Giuntoli Robert⁷,Roden Richard⁵,Eshleman James R.⁵,Carvalho Jesus Paula⁸,Marie Suely Kazue Nagahashi⁸⁹,Papadopoulos Nickolas¹,Kinzler Kenneth W.¹,Vogelstein Bert¹,Diaz Luis A.¹

Affiliation:

1. The Ludwig Center for Cancer Genetics and Therapeutics, The Swim Across America Laboratory at Johns Hopkins, and The Howard Hughes Medical Institute at Johns Hopkins Kimmel Cancer Center, Baltimore, MD 21287, USA.

2. Department of Neurosurgery, The Johns Hopkins Medical Institutes, Baltimore, MD 21231, USA.

3. MyGenostics Inc., 801 West Baltimore Street, Suite 502L, Baltimore, MD 21201, USA.

4. Department of Otolaryngology–Head and Neck Surgery, The Johns Hopkins Medical Institutes, Baltimore, MD 21231, USA.

5. Department of Pathology, The Johns Hopkins Medical Institutes, Baltimore, MD 21231, USA.

6. Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

7. Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutes, Baltimore, MD 21231, USA.

8. Institute of Cancer of Sao Paulo State, School of Medicine, University of Sao Paulo, Sao Paulo 01246903, Brazil.

9. Departments of Pathology and Neurology, School of Medicine, University of Sao Paulo, Sao Paulo 01246903, Brazil.

Abstract

Mutant DNA from ovarian and endometrial tumors can be detected in Pap smear specimens through massively parallel sequencing.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference52 articles.

1. European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary Document

2. R. M. DeMay Practical Principles of Cytopathology (ASCP Press Chicago 2010).

3. N. Howlader A. M. Noone M. Krapcho N. Neyman R. Aminou S. F. Altekruse C. L. Kosary J. Ruhl Z. Tatalovich H. Cho A. Mariotto M. P. Eisner D. R. Lewis H. S. Chen E. J. Feuer K. A. Cronin SEER Cancer Statistics Review 1975-2009 (Vintage 2009 Populations); http://seer.cancer.gov/csr/1975_2009_pops09/.

4. Global estimates of cancer prevalence for 27 sites in the adult population in 2008.;Bray F.;Int. J. Cancer,2012

5. International Agency for Research on Cancer GLOBOCAN 2008 v1.2 Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10; http://globocan.iarc.fr.

Cited by 267 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single‐molecule epiallelic profiling of DNA derived from routinely collected Pap specimens for noninvasive detection of ovarian cancer;Clinical and Translational Medicine;2024-07-31

2. Integrated miRNA Profiling of Extracellular Vesicles from Uterine Aspirates, Malignant Ascites and Primary-Cultured Ascites Cells for Ovarian Cancer Screening;Pharmaceutics;2024-07-05

3. Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review;Cancer Medicine;2024-07

4. TP53 somatic evolution in cervical liquid-based cytology and blood from individuals with and without ovarian cancer and BRCA1 or BRCA2 germline mutations;Oncogene;2024-06-25

5. Cytology-histology correlation of atypical glandular cells on cervical Papanicolaou tests: A study of 628 cases;Journal of the American Society of Cytopathology;2024-06